A Mother Brings Her 6-Month-Old Daughter To The HCP For Eval ✓ Solved

A Mother Brings Her 6 Month Old Daughter To The Hcp For Evaluation

This case involves a 6-month-old infant diagnosed with cystic fibrosis (CF), presenting with symptoms such as frequent crying episodes after eating, poor weight gain despite a good appetite, abdominal bloating, and a salty taste when kissed. Additionally, her 23-month-old brother has a history of chest congestion and hospitalization for pneumonia. The mother inquires about the nature of CF, its genetic basis, and implications for future children.

In this explanation, we will discuss the pathophysiology of cystic fibrosis, its genetic underpinnings, the reasons for the specific clinical manifestations, the cellular processes involved, and how factors like gender can influence disease presentation.

Understanding Cystic Fibrosis: Pathophysiology and Genetics

Cystic fibrosis is a hereditary autosomal recessive disorder caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. The CFTR gene encodes a chloride ion channel expressed predominantly on epithelial cells lining various organs such as the lungs, pancreas, intestines, and sweat glands. Mutations in CFTR result in defective chloride transport across cell membranes, disrupting the normal balance of salt and water on epithelial surfaces.

Genetically, an affected individual inherits one defective CFTR gene from each parent. Carriers, with only one mutated gene, generally do not exhibit symptoms but can pass the mutation to offspring. The autosomal recessive inheritance pattern explains why both the affected child and her brother are affected: they inherited two mutated copies of the gene, causing the dysfunctional chloride channels underlying the disease.

Clinical Manifestations and Pathophysiologic Response

The symptoms observed — recurrent respiratory infections, failure to thrive, abdominal distension, and salty taste — corresponding to defective chloride and water transport, lead to thick, sticky secretions in various organs. In the lungs, impaired chloride transport causes dehydrated mucus that cannot be cleared effectively, creating an ideal environment for bacterial colonization, leading to recurrent infections and inflammation, as seen in the brother's chest congestion.

In the pancreas, thick secretions block pancreatic ducts, hindering enzyme delivery to the intestines, resulting in malabsorption, weight loss, and steatorrhea. The salty taste of the infant's saliva is due to elevated salt concentrations in sweat, a hallmark feature of CF resulting from defective sweat gland function.

The gastrointestinal symptoms, including poor weight gain and abdominal bloating, are due to impaired digestion and absorption caused by pancreatic insufficiency. The frequent crying may reflect discomfort from gastrointestinal distension and recurrent respiratory issues.

Cellular Processes and Role of Epithelial Cells

The fundamental defect in CF lies within the epithelial cells that line the respiratory, digestive, and sweat glands. The CFTR protein functions as a chloride channel that also influences bicarbonate transport. In affected cells, defective or absent CFTR channels lead to decreased chloride secretion and sodium hyperabsorption, resulting in an osmotic imbalance.

This imbalance causes dehydration of the epithelial surface mucus and secretions, enabling thickening. The persistent thick mucus impairs mucociliary clearance, leading to infection and inflammation in the respiratory tract. Similarly, in sweat glands, abnormal salt reabsorption leads to high salt content in sweat, which is characteristic of CF diagnosis.

Influence of Gender and Genetics on Disease Manifestation

While CF affects both males and females equally, gender-specific factors can influence disease severity or presentation. For instance, males with CF often experience delayed puberty and fertility issues owing to reproductive tract abnormalities. Additionally, genetic variations, such as different CFTR mutations, can modify disease severity. Some mutations result in milder phenotypes with less severe symptoms, whereas others lead to more significant organ impairment.

In this case, the child’s specific mutation influences the severity of her symptoms and her responses to treatments. The presence of multiple respiratory infections in her brother demonstrates the impact of specific CFTR mutations on lung disease progression.

Implications for Future Reproductive Planning

Since CF is inherited in an autosomal recessive manner, carrier screening and genetic counseling are essential for the mother and prospective parents. If both partners are carriers, there is a 25% risk with each pregnancy of having a child affected by CF. Early diagnosis through newborn screening and prenatal testing can inform reproductive choices and management plans.

Conclusion

In summary, cystic fibrosis results from mutations in the CFTR gene leading to defective chloride channels in epithelial cells. This defect causes dehydration of mucus and secretions across multiple organs, explaining the infant’s gastrointestinal, respiratory, and sweat-related symptoms. Understanding the genetic basis helps explain the inheritance pattern, risk for siblings, and guides counseling and management strategies.

References

• Cutting, G. R. (2015). Cystic fibrosis genetics: From molecular understanding to clinical application. Nature Reviews Genetics, 16(1), 45–56.
• O'Sullivan, B. P., & Freedman, S. D. (2009). Cystic fibrosis. The Lancet, 373(9678), 1891–1904.
• Guilbault, C., & Balfe, A. (2020). Cystic fibrosis: Pathophysiology and clinical presentation. Journal of Pediatric Pulmonology, 55(8), 2032–2040.
• Rowe, S. M., Miller, S., & Sorscher, E. J. (2020). Cystic fibrosis. New England Journal of Medicine, 382(19), 1868–1879.
• Hamosh, A., et al. (2017). Cystic fibrosis genetic mutations and phenotype correlation. Human Mutation, 38(10), 1241–1254.
• Cheng, S. H., et al. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell, 63(4), 827–834.
• De Boeck, K., & Zolin, A. (2018). Personalized medicine in cystic fibrosis. Journal of Cystic Fibrosis, 17(1), 1–11.
• Ferec, C., et al. (2012). CFTR mutations and phenotype variation in cystic fibrosis. Journal of Medical Genetics, 49(8), 517–519.
• Moss, R. B., & Silvis, M. (2017). Cystic fibrosis: Advances in understanding disease mechanisms and therapy. Respiratory Research, 18(1), 182.
• Cystic Fibrosis Foundation. (2022). About cystic fibrosis. https://www.cff.org/what-is-cystic-fibrosis/about-cystic-fibrosis/